Earlier this year, legislative power and unexplained phenomena collided when U.S. Senators Charles Schumer and Mike Rounds introduced the “Unidentified Anomalous Phenomena (UAP) Disclosure Act of 2023.”
Contained within this groundbreaking amendment is a provision concerning “eminent domain,” a government legal tool that is often associated with infrastructure and public interest. However, in the context of UAP, a look at the implications, ethical challenges, and legal complexities tied to applying eminent domain to technology of unknown origin and biological evidence of non-human intelligence (NHI) is warranted.
The UAP Act of 2023’s Eminent Domain clause has already sparked some debate amongst those with legal backgrounds that follow the subject. The current drafted legislation would allow the U.S. government to seize NHI technology and biological evidence. While it appears to grant access to undisclosed NHI discoveries for public benefit, the provision’s reach is broad, and will impact not only major defense contractors but also individuals, private corporations, and other entities involved in scientific explorations.
The challenge of appraising NHI technology for fair compensation and its potential disruption to national defense initiatives further complicates the matter.
What follows is an argument that introduces an alternative regulatory approach, which will help to promote compliance and transparency while preserving property rights and national security interests. The regulatory approach to the subject is a proper first step to safeguarding the balance between public interest and individual freedoms.
Hellbound and Down 